A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...
In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results